ties are mainly regulated by the Ca 2ϩ /calmodulin system Background. Macrophage-type nitric oxide synthase (NOS- [1] . In the kidney, NO derived from NOS-I and NOS-II) is expressed in glomerular mesangial cells in response to III is involved in the regulation of glomerular hemodyinflammatory cytokines. Nitric oxide (NO) has antithrombotic and cytostatic activities in glomerular diseases. Recent studies namics, water-electrolyte balance, and renin production have suggested that several vasoactive substances and growth [2] [3] [4] [5] [6] [7] . The third isoform of NOS, the macrophage-type factors modulate NO production in a tissue-specific manner.
NOS (NOS-II), is normally undetectable in renal tissue.
The aim of this study was to examine whether angiotensin II NOS-II is induced by the stimulation of inflammatory and transforming growth factor-␤ (TGF-␤) modulate cytokinestimulated NO production and NOS-II gene expression in rat cytokines such as interleukin-1␤ (IL-1␤), tumor necrosis glomerular mesangial cells.
factor-␣, and interferon-␥ (INF-␥) in mesangial cells.

Methods. Cultured rat mesangial cells were incubated with
Once induced, NOS-II is active for a prolonged period interleukin-1␤ (IL-1␤) for 24 hours. The effects of angiotensin and produces large amounts of NO. In experimental II and TGF-␤ on stimulated nitrite accumulation and NOS-II glomerulonephritis, NO has been demonstrated to premRNA levels were determined.
Results. Angiotensin II and TGF-␤ significantly decreased vent glomerular thrombosis and ischemia [8] [9] [10] . Fur- modulates NO formation in mesangial cells. Angiotensin
Conclusions. These results suggest that in mesangial cells, angiotensin II and TGF-␤ participate in the inhibitory regula-II plays an important role in the progression of glomerution of cytokine-induced NO production. TGF-␤ inhibits NO lar diseases. It stimulates extracellular matrix protein production by decreasing NOS-II mRNA levels, whereas angiosynthesis and mesangial proliferation, thereby opposing tensin II may regulate NO production at the levels after NOS-II the effects of NO in the glomerulus. The clinical relegene expression. An autocrine action of TGF-␤ induced by anvance of the renal angiotensin system has been impligiotensin II is unlikely to contribute to angiotensin II-mediated inhibition of NO production.
cated by the beneficial effects of angiotensin-converting enzyme inhibitors on various types of glomerular diseases, such as glomerulonephritis, nephrosclerosis, and The biosynthesis of nitric oxide (NO) is catalyzed by diabetic nephropathy [14] [15] [16] . Angiotensin II exhibits three isoforms of nitric oxide synthase (NOS). The neuthese actions at least partly through an induction of transroneal-type NOS (NOS-I) and endothelial-type NOS forming growth factor-␤ (TGF-␤) in mesangial cells [17] [18] [19] . It is therefore speculated that an inhibition of NO production might be one of the mechanisms by which
METHODS
were then incubated in the test medium containing IL-1␤ with or without the test compounds for 24 hours. Materials RPMI 1640 medium, fetal bovine serum, trypsin, and Nitrite analysis ITS-Supplement were purchased from GIBCO BRL The levels of nitrite, a stable metabolite of NO, in the (Gaithersburg, MD, USA). Recombinant human IL-1␤, medium were used as an index of NO production [20] [21] [22] [23] . IL-6, and INF-␥ derived from E. coli were from Fujisawa-
The medium was mixed with an equal volume of Griess Pharmingen (Tokyo, Japan). Recombinant human TGFreagent containing 1% sulfanilamide, 0.1% naphthyleth-␤1 derived from CHO cells and chicken anti-TGF-␤ IgY ylenediamine dihydrochloride, and 2% phosphoric acid antibody were purchased from R&D Systems (Minneapfor 10 minutes. The absorbance at 540 nm was measured olis, MN, USA). Other chemicals were obtained from triplicate with a 96-well plate reader (Immunoreader; Sigma Chemical (St. Louis, MO, USA).
Intermed, Tokyo, Japan), and the nitrite concentration The ED 50 , as determined by the dose-dependent stimuwas determined using a calibration curve with sodium lation of thymidine uptake by mouse C3H/HeJ thymonitrite standards. cytes, and the specific activity of IL-1␤ were 0.1 ng/ml Isolation of RNA and Northern blot analysis and 10 7 U/mg, respectively. The ED 50 and the specific activity of IL-6 were 0.1 ng/ml and 10 7 U/mg, respectively. The levels of NOS-II mRNA were determined by The ED 50 , as determined by the dose-dependent inducNorthern blot analysis, as described previously [4, 5, 7] . tion of resistance to vesicular stomatitis virus by WISH Mesangial cells were washed twice with ice-cold 10 mm cells, and the specific activity of INF-␥ were 0.15 ng/ml phosphate-buffered saline (pH 7.4), and total RNA was and 6.7 ϫ 10 6 U/mg, respectively. The ED 50 of TGF-␤, as extracted by acid guanidinium thiocyanate-phenol-chloroform method [24] . Twenty micrograms of RNA were determined by the inhibition of the murine IL-4-depenloaded on 1% agarose gel, size fractionated, and transdent thymidine incorporation by HT-2 cells, was 0.02 to ferred to nylon membrane filters (Gene Screen Plus; 0.06 ng/ml. Anti-TGF-␤ antibody purified from egg yolk DuPont-NEN, Boston, MA, USA). The membranes was specific for neutralizing the biologic activity of rewere hybridized with 32 P-random-labeled rat NOS-II combinant human TGF-␤1. This antibody showed less cDNA probe (10 6 cpm/ml) [25] for 24 hours at 60ЊC. The than 10% cross-reactivity with TGF-␤5, less than 2% membranes were then washed twice with 2 ϫ standard cross-reactivity with TGF-␤2 and TGF-␤3, and no crosssaline citrate (SSC) containing 1% sodium dodecyl sulreactivity with other cytokines. The ND 50 of anti-TGF-␤ fate (SDS) for 30 minutes at 60ЊC and twice with 0.1 ϫ antibody, as defined by the concentration required to SSC for 15 minutes at room temperature. Radioactive yield one half of the maximal inhibition of the activity signals of the hybridized membranes were analyzed using of a supramaximal concentration (0.25 ng/ml) of recoma bioimaging analyzer FUJIX BAS-2000 (Fuji Film, binant human TGF-␤1 on HT-2 cells, as described earlier Tokyo, Japan). The NOS-II probe was stripped with here, was 0.2 to 0.6 g/ml.
boiling 0.1 ϫ SSC/1% SDS, and the membranes were rehybridized with a 32 P-labeled 18S ribosomal RNA probe.
Mesangial cell culture
Kidneys were removed from male Sprague-Dawley Statistical analysis rats weighing 150 to 200 g, and the cortex was dissected.
Data are expressed as means Ϯ se, and statistical sigThe glomeruli were isolated from minced cortex by passnificance was determined by unpaired t-test, linear reing through 250, 149, and 53 m mesh sieves. Mesangial gression analysis, or analysis of covariance. P values less cells were cultured from isolated glomeruli after the than 0.01 were considered statistically significant. treatment of 0.25% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA). Cells were grown in RPMI RESULTS 1640 medium containing 20% fetal bovine serum, 100 U/ml penicillin, 100 g/ml streptomycin, and ITS-SuppleNitric oxide formation and NOS-II gene expression ment at 37ЊC in 5% CO 2 and 95% air. The outgrowing stimulated by interleukin-1␤ cells were identified as mesangial cells by spindle-shaped As shown in Figure 1 , the incubation of cultured mesmorphology, positive immunohistochemical staining for angial cells with IL-1␤ for 24 hours resulted in doserat Thy-1.1 antigen, smooth muscle cell actin, desmin, dependent increases in NO production and NOS-II gene and vimentin and were negative for factor VIII. The cells expression. The highest dose (100 U/ml) of IL-1␤ prowere studied between passages 3 and 5. Confluent mesanduced approximately sixfold increases in the levels of gial cells were incubated in phenol red-free test medium nitrite and NOS-II mRNA. In our experiments, other supplemented with 0.1% bovine serum albumin and ITScytokines did not influence NO formation or NOS-II gene expression (Table 1) . Supplement for 48 hours before the experiments. They lated NO production and NOS-II gene expression in a a P Ͻ 0.01 vs. vehicle-treated control dose-dependent manner (Fig. 3) . When 5 ng/ml of TGF-␤ b P Ͻ 0.01 vs. IL-1␤ alone was applied, the mean nitrite concentration and the NOS-II mRNA level were decreased by 80% and 60%, respectively. This inhibitory effect of TGF-␤ was abolEffect of angiotensin II on interleukin-1␤-stimulated ished by TGF-␤-neutralizing antibody. The treatment nitric oxide formation of this antibody alone did not affect NO production or When mesangial cells were coincubated with angioten-NOS-II gene expression. sin II, IL-1␤-stimulated nitrite levels were significantly It has been suggested that angiotensin II induces TGF-␤ decreased ( Fig. 2A) . The highest concentration (10 Ϫ6 m) secretion from mesangial cells. To examine whether the of angiotensin II reduced the mean nitrite level by apinhibitory effect of angiotensin II on NO production was proximately 40%. This angiotensin II-mediated inhibimediated by an autocrine action of TGF-␤, IL-1␤-stimution of NO production was prevented by 10 Ϫ5 m of the lated mesangial cells were coincubated with angiotensin II angiotensin type 1 (AT1) receptor antagonist CV11974
and TGF-␤-neutralizing antibody. As shown in Figure 4 , ( Fig. 2A) , whereas the same concentration of PD123319, this antibody did not reverse the effect of angiotensin II. an angiotensin type 2 (AT2) receptor antagonist, did Effect of angiotensin II and transforming growth not alter the effect of angiotensin II (data not shown).
factor-␤ on the stability of NOS-II gene CV11974 alone did not affect NO formation.
To examine whether angiotensin II-mediated inhibiAfter the stimulation of IL-1␤ (100 U/ml) for 24 hours, mesangial cells were treated with vehicle, angiotensin II, tion of NO production was associated with changes in or TGF-␤ under the presence of 5 g/ml of actinomycin myocytes [23] . This study demonstrated that in mesangial cells, angiotensin II and TGF-␤ significantly decreased D. NOS-II mRNA levels divided by 18S rRNA levels were determined at one, two, four, and eight hours (Fig. IL-1␤-stimulated NO formation. This angiotensin IImediated inhibition of NO production was reversed by 5). The half-life of NOS-II mRNA was approximately 2.3 hours in the vehicle-treated group. Angiotensin II CV11974, thereby indicating that the AT1 receptor is responsible for the effect of angiotensin II. The local did not alter the half-life of NOS-II mRNA, whereas TGF-␤ significantly reduced it to approximately 1.5 levels of angiotensin II in the glomerular space may be sufficient to affect NO release in vivo [28] . The inhibitory hours. An analysis of covariance indicated the probabileffect of TGF-␤ on NO production is consistent with the ity that the slopes from vehicle-and TGF-␤-treated results of an earlier study [29] . These results suggest that groups were the same at less than 0.01.
angiotensin II and TGF-␤ negatively regulate cytokinestimulated NO production in mesangial cells.
DISCUSSION
Because angiotensin II induces secretion of TGF-␤ In glomerulonephritis, inflammatory cytokines are sefrom mesangial cells [18, 19] , it could be argued that the creted locally in glomeruli and affect mesangial cell funcinhibitory effect of angiotensin II on NO production was tions [26, 27] . As demonstrated in this study, mesangial mediated through TGF-␤ secretion. As demonstrated cells express NOS-II gene and produce large amounts in this study, TGF-␤ is a potent inhibitor of NOS-II of NO in response to IL-1␤. It has been demonstrated expression. TGF-␤-neutralizing antibody, however, did that NOS-II-derived NO is regulated by several of vasonot alter the effect of angiotensin II. This antibody comconstrictors and cell growth factors. Angiotensin II and pletely reversed TGF-␤-mediated inhibition of NO pro-TGF-␤ are known to inhibit cytokine-induced NO production. Therefore, an autocrine action of TGF-␤ on duction in vascular smooth muscle cells, macrophages, mesangial cells is unlikely to contribute to the effect of and astroglial cells [12, 13, [20] [21] [22] . In contrast, angiotenangiotensin II. Angiotensin II and TGF-␤ have been implicated in sin II was shown to augment NO synthesis in cardiac during the course of glomerulonephritis [8] [9] [10] . In cultured mesangial cells, NO inhibits mesangial proliferation and extracellular matrix protein synthesis [11] . The results of this study suggest that decreased NO production might be one of the mechanisms by which angiotensin II and TGF-␤ accelerate glomerular injury. Selective modulation of this mechanism will find potential applications in therapy in glomerular diseases.
In our study, angiotensin II failed to affect NOS-II mRNA levels in mesangial cells, whereas TGF-␤ markedly reduced them. Earlier studies have demonstrated that angiotensin II and TGF-␤ regulate NOS-II gene expression in a tissue-specific manner. In vascular smooth muscle cells and astroglial cells, angiotensin II decreases NO production by inhibiting NOS-II gene expression levels of NOS-II mRNA [31] . TGF-␤ was shown to decrease NO production in macrophages by three distinct mechanisms, including decreased stability and translation of NOS-II mRNA and increased degradation of the progression of glomerular diseases by stimulating NOS-II protein [20] . Although TGF-␤ decreases stimumesangial cell growth and extracellular matrix protein lated NO production in vascular smooth muscle cells, it synthesis [19, 30] . In addition, angiotensin II is a major remains controversial how TGF-␤ regulates NOS-II gene cause of glomerular hypertension, thereby promoting expression [21, 22] . In our study, in glomerular mesangial glomerulosclerosis [14] [15] [16] . In contrast, NO has been shown to prevent glomerular thrombosis and ischemia cells, NOS-II mRNA levels and the half-life of the mes-
